Advertisement
Central Surgical Association| Volume 82, ISSUE 3, P407-413, September 1977

Download started.

Ok

Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type II

  • Duane T. Freier
    Correspondence
    Reprint requests: Duane T. Freier, M.D., Chief, Surgical Service, Veterans Administration Hospital, 2215 Fuller Rd., Ann Arbor, MI 48105.
    Affiliations
    From the Departments of Surgery, Medicine, and Pathology, University of Michigan Medical Center Ann Arbor, Mich. U.S.A.

    From Surgical Service, Veterans Administration Hospital, Ann Arbor, Mich. U.S.A.
    Search for articles by this author
  • Norman W. Thompson
    Affiliations
    From the Departments of Surgery, Medicine, and Pathology, University of Michigan Medical Center Ann Arbor, Mich. U.S.A.

    From Surgical Service, Veterans Administration Hospital, Ann Arbor, Mich. U.S.A.
    Search for articles by this author
  • James C. Sisson
    Affiliations
    From the Departments of Surgery, Medicine, and Pathology, University of Michigan Medical Center Ann Arbor, Mich. U.S.A.

    From Surgical Service, Veterans Administration Hospital, Ann Arbor, Mich. U.S.A.
    Search for articles by this author
  • Ronald H. Nishiyama
    Affiliations
    From the Departments of Surgery, Medicine, and Pathology, University of Michigan Medical Center Ann Arbor, Mich. U.S.A.

    From Surgical Service, Veterans Administration Hospital, Ann Arbor, Mich. U.S.A.
    Search for articles by this author
  • John E. Freitas
    Affiliations
    From the Departments of Surgery, Medicine, and Pathology, University of Michigan Medical Center Ann Arbor, Mich. U.S.A.

    From Surgical Service, Veterans Administration Hospital, Ann Arbor, Mich. U.S.A.
    Search for articles by this author
DOI:https://doi.org/10.5555/uri:pii:0039606077901532
Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type II
Previous ArticleNonpenetrating trauma to the thoracic aorta
Next ArticleErratum
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Fifteen patients with the diagnosis of multiple endocrine adenomatosis, type II, syndrome (MEA II) were reported from a single center to discuss the dilemmas of early detection and treatment of the adrenal medullary, thyroid, and parathyroid gland diseases. Ten patients came from three families. Three of the patients died, none in hypertensive crisis. Bilateral adrenal medullary disease was present in six patients. Five patients with proved pheochromocytoma had hypertension. All had diagnostic urinary catecholamine values. Nine normotensive patients without proved pheochromocytoma, but in a high-risk category for adrenal medullary disease, have multiple suspicious urinary catecholamines suggestive of adrenal medullary hyperplasia. Bilateral adrenalectomy is recommended for proved adrenal medullary disease in the MEA II syndrome. Medullary carcinoma of the thyroid gland was found in 13 patients and is believed to be present in two others. Five of the proved cases were occult, being discovered by elevation of pentagastrin-stimulated serum calcitonin levels, justifying total thyroidectomy. Parathyroid hyperplasia was found in three patients with preoperative hypercalcemia and in four others with preoperative normocalcemia. Conservative treatment of parathyroid gland hyperplasia in the MEA II syndrome is substantiated. Metachronous phenotypic expression of the syndrome components was significant.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Block M.A.
        • Jackson C.E.
        • Tashjian Jr., A.H.
        Management of parathyroid glands in surgery for medullary thyroid carcinoma.
        Arch Surg. 1975; 110: 617
        • Carney J.A.
        • Sizemore G.W.
        • Sheps S.G.
        Adrenal medullary disease in MEA, type 2.
        Am J Clin Pathol. 1976; 66: 279
        • Carney J.A.
        • Sizemore G.W.
        • Tyce G.M.
        Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2. The precursor of bilateral pheochromocytoma. Report of a single case.
        in: ed. 14. Mayo Clinic Proc. 50. 1975: 3
        • deOliveira L.A.R.
        • Coronho V.
        • Fernandes A.D.L.
        • et al.
        Treatment of Cushing's disease recurrence after bilateral total adrenalectomy and autotransplantation of the adrenal gland.
        Rev Assoc Med Bras. 1976; 22: 223
        • Drucker W.D.
        • Localio S.A.
        • Becker M.H.
        • et al.
        Autotransplantation of hyperplastic human adrenal tissue.
        Arch Intern Med. 1967; 120: 185
        • Dunn E.L.
        • Nishiyama R.H.
        • Thompson N.W.
        Medullary carcinoma of the thyroid gland.
        Surgery. 1973; 73: 848
        • Freier D.T.
        • Harrison T.S.
        Rigorous biochemical criteria for the diagnosis of pheochromocytoma.
        J Surg Res. 1973; 14: 177
        • Harrison T.S.
        • Thompson N.W.
        Multiple endocrine adenomatosis.
        Curr Prob Surg. August 1975;
        • Hill Jr., S.C.
        Medullary carcinoma of the thyroid gland.
        in: Seventh National Cancer Conference Proceedings. American Cancer Society, Sept., 1973: 163
        • Jackson C.E.
        • Tashjian Jr., A.H.
        • Block M.A.
        Detection of MCT by calcitonin assay in families.
        Ann Intern Med. 1973; 78: 845
        • Khairi M.R.
        • Dexter R.N.
        • Burzynski N.J.
        • et al.
        Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: Multiple endocrine neoplasia, type 3.
        Medicine. 1975; 54: 89
        • Liddle G.W.
        ed. 14. Textbook of medicine. W. B. Saunders Co, Philadelphia1975: 1739
        • Ljungberg O.
        • Aderquist E.
        • von Studnitz W.
        Medullary thyroid carcinoma and pheochromocytoma, a familial chromaffinomatosis.
        Br Med J. 1967; 1: 279
        • Sheps S.G.
        • Maher F.T.
        Histamine and glucagon tests in diagnosis of pheochromocytoma.
        JAMA. 1968; 205: 895
        • Siqueira-Filho A.G.
        • Sheps S.G.
        • Maher F.T.
        • et al.
        Glucagon-blood catecholamine test, use in isolated and familial pheochromocytoma.
        Arch Intern Med. 1975; 135: 1227
        • Taniguchi T.
        • Kakimoto Y.
        • Armstrong M.
        Quantitative determination of metanephrine and normetanephrine in urine.
        J Lab Clin Med. 1964; 64: 469
        • Telenius-Berg M.
        Diagnostic studies in medullary carcinoma of the thyroid.
        Acta Med Scand Suppl. 1977; : 597
        • von Euler U.S.
        • Lishajko F.
        Improved technique for the fluorometric estimation of catecholamines.
        Acta Physiol Scand. 1961; 5: 348

      Article info

      Footnotes

      ☆Presented at the Thirty-fourth Annual Meeting of the Central Surgical Association, Buffalo, N. Y., March 3–5 1977.

      Identification

      DOI: https://doi.org/10.5555/uri:pii:0039606077901532

      Copyright

      © 1977 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX